Fingerprint
Dive into the research topics of 'Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma
Omid Hamid, Caroline Robert, Adil Daud, F. Stephen Hodi, Wen Jen Hwu, Richard Kefford, Jedd D. Wolchok, Peter Hersey, Richard W. Joseph, Jeffrey S. Weber, Roxana Dronca, Tara C. Gangadhar, Amita Patnaik, Hassane Zarour, Anthony M. Joshua, Kevin Gergich, Jeroen Elassaiss-Schaap, Alain Algazi, Christine Mateus, Peter Boasberg
Research output: Contribution to journal › Article › peer-review
2441
Scopus
citations